Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary) ; Teriparatide (Primary) ; Zoledronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms DATA-HD
- 01 Nov 2019 Results published in the Journal of Clinical Endocrinology and Metabolism
- 14 Mar 2019 Planned End Date changed from 1 Dec 2019 to 1 Jan 2020.
- 14 Mar 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Jan 2020.